Oral mucous membrane pemphigoid: updates in diagnosis and management

Roopali Kulkarni1, Eric T Stoopler2, Thomas P Sollecito3

  • 1Assistant Professor of Oral Medicine, Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, Pennsylvania, USA.

British Dental Journal
|February 22, 2024
PubMed

Insights

Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease affecting oral and conjunctival tissues. Early recognition and management by dentists are crucial to prevent severe complications like blindness.

Area of Science:

  • Oral Medicine
  • Dermatology
  • Immunology

Background:

  • Mucous membrane pemphigoid (MMP) is a rare, chronic autoimmune blistering disease.
  • It primarily affects mucous membranes, particularly the oral cavity and conjunctiva.
  • Autoantibodies target hemidesmosomal proteins, commonly BP180, in the basement membrane zone.

Purpose of the Study:

  • To provide an overview of mucous membrane pemphigoid.
  • To highlight the importance of dental professionals in recognizing and managing MMP.
  • To discuss diagnostic criteria and treatment strategies for MMP.

Main Methods:

  • Literature review of autoimmune blistering diseases.
  • Analysis of clinical presentation, diagnosis, and management of MMP.
  • Emphasis on differential diagnosis from other vesiculobullous conditions.

Main Results:

  • MMP presents with gingival desquamation, erosions, and ulcerations.
  • Diagnosis relies on clinical findings, biopsy, and serology.
  • Effective management involves corticosteroids, immunosuppressants, and biologics for severe cases.

Conclusions:

  • MMP requires prompt diagnosis and multidisciplinary management.
  • Dentists play a vital role in the early detection and care of oral manifestations of MMP.
  • Timely intervention is essential to prevent potentially blinding complications.

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
303
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
429
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
90